Allergy Relief 25 Mg Capsule
NDC Package 73057-348-11

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Allergy Relief 25 Mg (diphenhydramine hcl 25mg) capsules is take every 4 to 6 hours, or as directed by a doctordo not exceed 6 doses in 24 hours adults and children 12 years and over 1 to 2 capsules children 6 to under 12 years 1 capsule children under 6 yearsask a doctor. This formulation utilizes a capsule delivery system. Marketed by Ulai Health Llc, this product is identified by NDC 73057-348 and is authorized under FDA application M010.

Identification & Billing

NDC Package Code
73057-348-11
Package Description
1000 CAPSULE in 1 BOTTLE, PLASTIC
Product Code
73057-348
11-Digit Billing Format
73057034811
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Allergy Relief 25 Mg
Non-Proprietary Name
Diphenhydramine Hcl 25mg
Substance Name
Diphenhydramine Hydrochloride
Dosage Form
Capsule - A solid oral dosage form consisting of a shell and a filling. The shell is composed of a single sealed enclosure, or two halves that fit together and which are sometimes sealed with a band. Capsule shells may be made from gelatin, starch, or cellulose, or other suitable materials, may be soft or hard, and are filled with solid or liquid ingredients that can be poured or squeezed.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
DIPHENHYDRAMINE HYDROCHLORIDE 25 mg/1
Pharmacologic Class
Usage Information
Take every 4 to 6 hours, or as directed by a doctordo not exceed 6 doses in 24 hours adults and children 12 years and over 1 to 2 capsules children 6 to under 12 years 1 capsule children under 6 yearsask a doctor

Regulatory & Marketing

Labeler Name
Ulai Health Llc
Product Type
Human Otc Drug
FDA Application #
M010
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
07-01-2019
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (73057-348). Click a package code to view its specific billing and regulatory data.

73057-348-03
24 CAPSULE in 1 BOTTLE, PLASTIC
73057-348-08
100 CAPSULE in 1 BOTTLE, PLASTIC

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 73057-348-11 identifies a specific commercial package of 1000 capsule in 1 bottle, plastic of Allergy Relief 25 Mg, a human over the counter drug labeled by Ulai Health Llc. This capsule is formulated for oral use and contains diphenhydramine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Ulai Health Llc on July 01, 2019. The current certification is valid through December 31, 2026.

How is this Ulai Health Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 73057034811. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
73057-348-11
11-Digit CMS (5-4-2)
73057-0348-11

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.